S
AXSM icon

SignatureFD’s Axsome Therapeutics AXSM Stock Holding History

SignatureFD’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.7K Hold
229
– – ﹤0.01% 1877
2025
Q4 		$41.8K Hold
229
– – ﹤0.01% 1754
2025
Q3 		$27.8K Hold
229
– – ﹤0.01% 1952
2025
Q2 		$23.9K Sell
229
-100
-30% -$10.6K ﹤0.01% 1973
2025
Q1 		$38.4K Hold
329
– – ﹤0.01% 1729
2024
Q4 		$27.8K Hold
329
– – ﹤0.01% 1895
2024
Q3 		$29.6K Buy
329
+16
+5% +$1.4K ﹤0.01% 1854
2024
Q2 		$25.2K Hold
313
– – ﹤0.01% 1846
2024
Q1 		$25K Buy
313
+240
+329% +$20.1K ﹤0.01% 1884
2023
Q4 		$5.81K Sell
73
-64
-47% -$4.28K ﹤0.01% 2456
2023
Q3 		$9.57K Buy
137
+64
+88% +$4.78K ﹤0.01% 2231
2023
Q2 		$5.25K Sell
73
-20
-22% -$1.48K ﹤0.01% 2499
2023
Q1 		$5.74K Sell
93
-634
-87% -$41.7K ﹤0.01% 2455
2022
Q4 		$56.1K Buy
727
+627
+627% +$37.5K ﹤0.01% 1302
2022
Q3 		$4K Hold
100
– – ﹤0.01% 2496
2022
Q2 		$4K Sell
100
-27
-21% -$854 ﹤0.01% 2494
2022
Q1 		$5K Sell
127
-451
-78% -$14K ﹤0.01% 2460
2021
Q4 		$22K Buy
578
+320
+124% +$11.8K ﹤0.01% 1736
2021
Q3 		$9K Buy
258
+166
+180% +$6.47K ﹤0.01% 2101
2021
Q2 		$6K Buy
92
+15
+19% +$900 ﹤0.01% 2184
2021
Q1 		$4K Buy
77
+62
+413% +$4.36K ﹤0.01% 2205
2020
Q4 		$1K Buy
15
+2
+15% +$150 ﹤0.01% 2386
2020
Q3 		$1K Buy
+13
New +$1.01K ﹤0.01% 2366

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SignatureFD's AXSM Position: Q1 2026 in Review

SignatureFD held its Axsome Therapeutics (AXSM) position steady in Q1 2026 at 229 shares worth $38.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1877.

SignatureFD first reported a position in AXSM in Q3 2020 and has held it in 23 quarters since. The position peaked at $56.1K in Q4 2022. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • SignatureFD held 229 shares of Axsome Therapeutics worth $38.7K as of Q1 2026.
  • SignatureFD left its Axsome Therapeutics share count unchanged in Q1 2026.
  • Axsome Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q1 2026, its #1877 holding.
  • SignatureFD first reported a position in Axsome Therapeutics in Q3 2020 and has held it in 23 quarters since.
  • SignatureFD's Axsome Therapeutics position peaked at $56.1K in Q4 2022.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.